AbGenomics Corp.

AbGenomics Corp.

Part of the AbGenomics Group, including AbGenomics International Inc., a clinical-stage biopharmaceutical company located in the San Francisco Bay Area.

Involved in the discovery and development of therapeutic antibodies for immune-related inflammatory diseases, allergy, asthma, transplantation rejection, and cancer.

Lead candidate AbGn-168H (Neihulizumab) has demonstrated the proof of clinical efficacy in Phase II clinical trials for T-cell mediated diseases such as psoriasis and psoriatic arthritis.

2F, No. 36, Lane 358
Juikuang Rd, Neihu
Taipei 114, Taiwan
– na –

Send Message to listing owner

AbGenomics Corp.